MedX Health Corp (CVE:MDX – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as C$0.10 and last traded at C$0.09, with a volume of 131500 shares changing hands. The stock had previously closed at C$0.10.
MedX Health Stock Performance
The firm has a market cap of C$24.89 million, a P/E ratio of -3.00 and a beta of 1.41. The firm’s fifty day moving average price is C$0.07 and its 200 day moving average price is C$0.06.
MedX Health (CVE:MDX – Get Free Report) last released its quarterly earnings results on Wednesday, March 6th. The company reported C($0.53) earnings per share (EPS) for the quarter. The business had revenue of C$26.41 million for the quarter. As a group, analysts expect that MedX Health Corp will post 0.0037531 earnings per share for the current fiscal year.
About MedX Health
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market.
See Also
- Five stocks we like better than MedX Health
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Garmin Navigates to New Highs Driven By Wearables Trend
- High Flyers: 3 Natural Gas Stocks for March 2022
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Comparing and Trading High PE Ratio Stocks
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
